BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24470513)

  • 21. Hedgehog signaling and the Gli code in stem cells, cancer, and metastases.
    Ruiz i Altaba A
    Sci Signal; 2011 Nov; 4(200):pt9. PubMed ID: 22114144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
    Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer.
    Stotz M; Pichler M; Absenger G; Szkandera J; Arminger F; Schaberl-Moser R; Samonigg H; Stojakovic T; Gerger A
    Br J Cancer; 2014 Jan; 110(2):435-40. PubMed ID: 24357796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
    Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
    Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer.
    Raz G; Allen KE; Kingsley C; Cherni I; Arora S; Watanabe A; Lorenzo CD; Edwards V DK; Sridhar S; Hostetter G; Weiss GJ
    Lung Cancer; 2012 May; 76(2):191-6. PubMed ID: 22115706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
    Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX9 expression predicts relapse of stage II colon cancer patients.
    Marcker Espersen ML; Linnemann D; Christensen IJ; Alamili M; Troelsen JT; Høgdall E
    Hum Pathol; 2016 Jun; 52():38-46. PubMed ID: 26980019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
    Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
    ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
    Absenger G; Szkandera J; Stotz M; Postlmayr U; Pichler M; Ress AL; Schaberl-Moser R; Loibner H; Samonigg H; Gerger A
    Anticancer Res; 2013 Oct; 33(10):4591-4. PubMed ID: 24123035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX.
    Lee DW; Kim KJ; Han SW; Lee HJ; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
    Ann Surg Oncol; 2015 Jan; 22(1):187-94. PubMed ID: 24889488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
    Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
    Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hedgehog signaling pathway and vitamin D receptor gene variants as potential risk factors in odontogenic cystic lesions.
    Magic M; Zeljic K; Jovandic S; Stepic J; Pejovic M; Colic S; Magic Z; Supic G
    Clin Oral Investig; 2019 Jun; 23(6):2675-2684. PubMed ID: 30334169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways.
    Lees CW; Zacharias WJ; Tremelling M; Noble CL; Nimmo ER; Tenesa A; Cornelius J; Torkvist L; Kao J; Farrington S; Drummond HE; Ho GT; Arnott ID; Appelman HD; Diehl L; Campbell H; Dunlop MG; Parkes M; Howie SE; Gumucio DL; Satsangi J
    PLoS Med; 2008 Dec; 5(12):e239. PubMed ID: 19071955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A common gene variant in PLS3 predicts colon cancer recurrence in women.
    Szkandera J; Winder T; Stotz M; Weissmueller M; Langsenlehner T; Pichler M; Samonigg H; Renner W; Gerger A; Absenger G
    Tumour Biol; 2013 Aug; 34(4):2183-8. PubMed ID: 23549633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival.
    Yadav A; Gupta A; Yadav S; Rastogi N; Agrawal S; Kumar A; Kumar V; Misra S; Mittal B
    Tumour Biol; 2016 Jun; 37(6):8083-95. PubMed ID: 26715268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer.
    Young JI; Mongoue-Tchokote S; Wieghard N; Mori M; Vaccaro GM; Sheppard BC; Tsikitis VL
    Dis Colon Rectum; 2016 Apr; 59(4):306-15. PubMed ID: 26953989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in sporadic colon cancer with high-level microsatellite instability.
    Oh BY; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    Surgery; 2016 May; 159(5):1372-81. PubMed ID: 26775578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
    Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
    Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients.
    Szkandera J; Pichler M; Absenger G; Stotz M; Arminger F; Weissmueller M; Schaberl-Moser R; Samonigg H; Kornprat P; Stojakovic T; Avian A; Gerger A
    Am J Surg; 2014 Aug; 208(2):210-4. PubMed ID: 24581872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.